MedTrace Logo

Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use

NCT07783113 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-08-27

No results posted yet for this study

Summary

A single-center, open-label clinical study to evaluate whether a dietary supplement can reduce hair loss in women with GLP-1-associated telogen effluvium. Participants will use the supplement for 120 days. Researchers will evaluate hair loss, hair density, and hair growth through clinical assessments, hair measurements (trichogram), and participant questionnaires.

Conditions

Interventions

DIETARY_SUPPLEMENT

Dietary Supplement for Hair Loss

Dietary supplement containing vitamins, minerals, amino acids, and silicon intended to support hair health and reduce hair loss.

Sponsors & Collaborators

  • Kosmoscience Ciência e Tecnologia Cosmética Ltda

    collaborator UNKNOWN

  • Farmoquimica S.A.

    lead INDUSTRY

Principal Investigators

  • Ana Lúcia T Tabarini Alves Pinheiro, MD · Kosmoscience Ciência e Tecnologia Cosmética Ltda

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07783113 on ClinicalTrials.gov